Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure



Status:Terminated
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:Any
Updated:1/25/2019
Start Date:December 2016
End Date:June 30, 2018

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Use of Near Infrared Spectroscopy in Preterm Infants to Determine Patent Ductus Arteriosus Closure Following Medical Treatment

Using cerebral and renal near infrared spectroscopy monitoring to determine PDA closure in
preterm infants after completing medical treatment for a hemodynamically significant PDA.


Inclusion Criteria:

- preterm infants less than 32 weeks gestation

Exclusion Criteria:

- infection, congenital heart disease, syndromic anomalies, and perinatal asphyxia.
We found this trial at
1
site
Albany Medical Center Neonatal Intesive Care Unit
Albany, New York 12208
Principal Investigator: Kate A Tauber, MD
Phone: 518-262-5421
?
mi
from
Albany, NY
Click here to add this to my saved trials